In vascular smooth muscle, phorbol esters cause a slowly developing contraction and an associated transmembrane calcium flux, both of which are inhibited by dihydropyridine calcium channel antagonists. In the A7r5 cultured vascular cell line, we used the whole-cell voltage-clamp technique to identify voltage-dependent calcium conductances and investigate the effect of phorbol esters on that conductance having characteristic dihydropyridine sensitivity (slowly inactivating, high-threshold, "L-type"). With barium as the charge carrier, large-amplitude (100-800 pA) inward currents of two types were characterized by their kinetics and voltage dependence. With holding potential -80 mV, a rapidly inactivating, low-threshold current ("T-type") was activated by depolarizations above -40 raV and was maximal at -1 0 mV. With holding potential -30 raV, this component was inactivated, and a second slowly inactivating, high-threshold current was activated above -10 mV and was maximal at +10 to + 20 mV. These currents are similar to the T-type and L-type currents previously described in vascular smooth muscle cells. When added to the bath, the active phorbol ester, 12-Otetradecanoyl phorbol-13-acetate (100 nM) increased the slowly inactivating (L-type) current by 32 ±20% (n = 8,±SD). Phorbol-12,13-dibutyrate (100 nM) caused a similar effect, but the inactive  phorbol, 4-a-phorbol (100 nM) , did not. We conclude that at least two distinct calcium conductances are expressed in A7r5 vascular smooth muscle cells, and that the dihydropyridine-sensitive calcium conductance is acutely modulated by phorbol esters, presumably acting through stimulation of protein kinase C. Such modulation may play a role in increasing transmembrane calcium influx mediated by agonist-receptor interactions that lead to activation of protein kinase C and may help to sustain or amplify calcium-dependent cell responses. (Circulation
I n vascular smooth muscle flux studies, a number of agonists, including serotonin, acetylcholine, aadrenergic agonists, and growth factors, have been shown to increase transmembrane calcium flux in association with contractile activity. In a variety of tissues, including vascular smooth muscle, agonistreceptor interactions result in an increase in phosphoinositide turnover and the generation of at least two putative second messengers, inositol trisphosphate (IP 3 ) and diacylgrycerol (DAG) (reviewed in references 1 and 2). While IP 3 appears to mediate the rapid release of calcium from intracellular stores, DAG increases the activity of a calcium-dependent protein kinase, 1 -2 and may be responsible for the sustained phase of cellular response in a number of cell types 2 -" including vascular smooth muscle. 4 " 7 Protein kinase C can be stimulated directly by tumor-producing phorbol esters. 8 In vascular smooth muscle, phorbol esters cause a slowly developing contraction and an associated transmembrane calcium flux. 3 " 7 Both contraction and calcium flux are inhibited by dihydropyridine calcium channel antagonists as well as augmented by Bay K 8644. 7 Recently, 43 Ca flux studies in monolayers of A7r5 cells, a clonal cell line derived from rat aortic smooth muscle, 910 have demonstrated increased dihydropyridine-sensitive transmembrane calcium flux in response to the phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA).'' Another recent report 12 has shown, under different conditions, phorbol-esterinduced decrease of stimulated calcium flux in these cells following potassium chloride or Bay K 8644 pretreatment. Vasopressin-induced decreases of whole-cell calcium currents were also briefly described. Such modulation by dihydropyridines suggests that voltage-dependent calcium channels are involved in the transmembrane calcium flux induced by phorbol ester in A7r5 cells. In view of these interesting studies, 11 " 13 it is clear that further electrophysiological studies are needed to better understand how voltagedependent calcium channels contribute to the effects of phorbol esters on contraction.
Electrophysiological studies in a number of other preparations suggest that the effect of phorbol esters is particular to cell type. In Apfysia neurons, intracellular injection of protein kinase C or pretreatment with a phorbol ester, TPA, has been found to increase the average voltage-dependent calcium current as compared with untreated cells, 14 an increase involving recruitment of covert calcium channels in a recent report. 13 In contrast, in avian neurons, phorbol esters cause acute decreases in voltage-dependent calcium conductance. 16 Therefore, we undertook to investigate possible electrophysiological effects of phorbol esters on the dihydropyridine-sensitive calcium conductance in A7r5 cells.
At least two types of calcium channels are present in nerve, 17 heart, 18 and smooth muscle, 19 " 21 characterized by voltage dependence of activation and inactivation, kinetics, and response to organic and inorganic blockers. In the nomenclature of Tsien and coworkers, 17 both T-type (transient, low-threshold) and L-type (long-lasting, high-threshold) calcium channels have been characterized in vascular smooth muscle. 19 " 21 In rat mesenteric artery cells, Bean et al 19 found both types of calcium current and showed that the L-type calcium current was the more sensitive to block by nitfendipine.
Using the whole-cell patch-clamp configuration in single A7r5 cells, we identified large, stable calcium currents of two types, similar to the T-type and L-type currents previously described. As in previous studies, the L-type current was blocked by the dihydropyridine, nitrendipine. We therefore used this model system to test the hypothesis that protein kinase C can acutely modulate the calcium current in vascular smooth muscle cells, by measuring the response of the peak L-type current in single cells to applications of 20 mM barium modified Ringer's solution, inactive phorbol ester, and the active phorbol esters TPA and phorbol-12,13-dibutyrate (PDBu). Some of these results have been previously reported as an abstract.
Materials and Methods

Cell Culture and Preparation
The A7r5 rat aortic smooth muscle cell line 9 was obtained from the American Type Culture Collection, Bethesda, Maryland. As previously described, 11 cells were plated at an initial density of 5,00(3-9,000 cells/cm 2 , and grown in Dulbecco's Modified Eagle Medium (GIBCO, Grand Island, New York) containing antibiotics and 10% fetal calf serum (GIBCO) in a humidified atmosphere (37° C) under 5% CO 2 -95% air. Cells reached confluence at approximately 4 days and were used for studies between 5 and 8 days, at which time there were approximately 35,000 cells/ cm 2 . Cells used for experiments were from passages 6 through 35, during which time they exhibited stable morphological characteristics by light microscopy and reproducible electrophysiological responses under whole-cell voltage-clamp. Immediately prior to each experiment, confluent cell layers were dispersed with trypsin solution containing 0.05% trypsin, 0.68 mM EDTA, in Hanks' medium (pH 7.4) for 7-10 minutes with periodic agitation, resuspended in Hanks' me-dium containing 10% fetal calf serum, and plated at a density of 5,000 cells/ml for use from 1 to 5 hours after plating.
Whole-Cell Patch-Clamp
Isolated cells were bath-perfused at 22° C with 20 mM Ba-modified Ringer's solution (NaCl 113 mM, KC1 4 mM, MgCl 2 2 mM, BaCl 2 20 mM, NaOH-HEPES 10 mM, pH 7.4) in the whole-cell patch-clamp configuration with cesium-containing solution (CsCl 120 mM, Cs-EGTA 10 mM, MgCl 2 1.4 mM, HEPES 10 mM, pH 7.2) in the patch pipette. In addition, the pipette solution contained 3.6 mM MgATP (Sigma Chemical, St. Louis, Missouri), 1 mM GTP (Sigma), 14.2 mM phosphocreatine (Sigma), and 50 units/ml creatine phosphokinase (Sigma) to minimize "washout" of the channels. Test agents added to the bath included 1) 100 nM 4-a-phorbol, 2) 100 nM TPA, 3) 100 nM PDBu, and 4) 1 \iM nitrendipine. Phorbol esters were diluted 1:10,000 from a stock solution in DMSO and were obtained from Sigma. Nitrendipine was diluted 1:1,000 from stock solution in ethanol, and was generously supplied by Miles Pharmaceuticals, West Haven, Connecticut.
Results
Characterization of Basal Calcium Currents
In the whole-cell voltage-clamp configuration, inward calcium currents were elicited under physiological conditions (2 mM Ca-Ringer's bath solution) by depolarizing step potentials from a holding potential of -80 mV. Two kinetic components were evident, and the slowly inactivating current was preferentially increased when barium was used as the charge carrier.
To study the slowly inactivating current, 20 mM Bamodified Ringer's was used as the standard bath solution. Under these conditions, large-amplitude (100-800 pA) inward currents of two types were elicited and distinguished by their kinetics and voltage dependence of activation and inactivation. Figure 1 shows single-cell inward current records with successive 400-msec depolarizing test pulses at 3-second intervals from a holding potential of -80 mV ( Figure  1A ) and from a holding potential of -30 mV ( Figure  IB) . With holding potential -8 0 mV, a rapidly inactivating, low-threshold current was activated at -40 to -30 mV, maximal at -10 mV, with time to peak of 11 ±1 msec (n = 4, ±SD) and half-time of decay of 14 ±2 msec {n = A, ±SD). This current is similar to the T-type current described in other preparations. A second slowly inactivating current, activated at a higher threshold, was also expressed with holding potential -80 mV. Both current components exhibited steady-state inactivation but with different ranges of voltage dependence. Thus, holding potentials of -3 0 raV completely inactivated the rapidly inactivating component, leaving the slow component expressed in isolation as shown in Figure IB mV, with time to peak of 24 ± 2 msec (n = 7, ± SD), corresponding to the L-type current previously described. Rates of inactivation for this slow component were highly variable with half-times ranging from 150 msec to many seconds. The current-voltage relations for the two current components of Figures 1A and IB is shown in Figure 1C . The fast current component was measured by subtracting the slow component, measured with holding potential -3 0 mV where it is minimally inactivated, from the sum of the two currents obtained at holding potential -80 mV. As shown in Figure 1C , depolarizing steps to -20 mV activated the fast current but were below the threshold for activating the slow current.
Multicell averages of steady-state inactivation curves for the fast (n = 8) and slow (« = 4) current components are plotted as a function of holding potential in Figure 2 . The fast current was completely inactivated at a holding potential of -30 mV with a half-inactivation point of -50 mV. This fast component of the same cell of Figure 1 is also shown for comparison. Some cells expressed only slow current; the inactivation of the isolated slow current measured in these cells is also shown in Figure 2 with a half-inactivation point of approximately -1 8 mV.
Effects of TPA and PDBu on Calcium Currents
Using a holding potential of -30 mV to inactivate the fast current, the acute effects of phorbol ester, added by bath perfusion, on the isolated slow current were studied. Slow current was measured with a series of test potentials from 0 to + 3 0 mV to define the peak of the current-voltage relation each time. As shown in Table  1 , TPA (100 nM) increased the magnitude of the peak slow current (as compared with pre-TPA control) by 12% to 66% in eight cells with an average of 32 ± 20% (n = 8, ± SD). Although the increases by TPA are not large, they are convincing since in the absence of TPA,
Holding Potential V R (mV) all cells showed a steady "rundown" of current (by a minimum of 15% in 5 minutes under our conditions). The time course of the augmentation by TPA is shown for a typical cell in Figure 3 . After an initial control period, TPA (100 nM) caused a relative increase in peak slow current while in the other cell shown, the inactive phorbol, 4-a-phorbol (100 nM), did not affect the course of slow rundown. (These increases were above control levels, i.e., increases are expressed relative to pre-phorbol current and not merely relative to the course of rundown.) In Figure 4 , sequential application of 4-a-phorbol and TPA in the same cell shows that TPA caused an increase in the slow current after the inactive phorbol did not. PDBu, another active phorbol, also increased the peak slow current above the course of rundown. The addition of 1 \iM nitrendipine to the bath abolished the current in cells previously stimulated by TPA (data not shown), confirming that he TPA-stimulated current was carried by slow, L-type, dihydropyridine-sensitive channels. The augmentation by TPA was not reversible, although rundown superimposed on augmentation complicated the measurement. TPA (100 nM) did not shift the voltage dependence of the L-type current by more than 10 mV negative. No significant change of whole-cell current kinetics was observed with any of the tested phorbol esters.
Discussion
Rasmussen et al, 6 -7 Danthuluri and Deth, 3 and others 22 ' 24 have observed that phorbol esters cause a slowly developing contraction in vascular smooth muscle. Most, 7 -22 but not all, 23 studies have suggested that TPA-induced vascular contraction is dependent on external calcium, since it is abolished or attenuated by the removal of external calcium. Forder et al 7 showed that the dihydropyridine calcium antagonist, nitrendipine, causes a substantial reduction in the amplitude of the TPA-induced contraction, suggesting that a significant amount of the associated transmembrane calcium flux passes through a dihydropyridine-sensitive membrane pathway. Using the A7r5 cell line, Sperti and Colucci" recently showed that TPA increased the initial rate of dihydropyridine-sensitive transmembrane 43 Ca influx in monolayers. That study suggested that the dihydropyridine-sensitive (presumably L-type) voltage-dependent calcium channel was modulated by phorbol activation of protein kinase C. These results are qualitatively similar to those in a preliminary report by Ruegg. l3 However, the recent study of Galizzi et al 12 found that preexposure of A7r5 cells to phorbol esters for 10 minutes inhibited KC1-or Bay K 8644-stimulated * 5 Ca uptake. The apparently different effects of phorbol ester on calcium flux in these two studies may be due to 1) different time periods studied (initial calcium uptake rate versus uptake after 10 minutes of phorbol ester preexposure), 2) inhibitory effects shown only in cells that had activated influx, and 3) substantially higher phorbol ester concentrations used by Galizzi et al (i.e., \C X = 25 nM versus < 3 nM in Sperti and Calucci). In both of these flux studies, it was not possible to discern the relative contributions of direct effects of protein kinase C activation on the calcium channels and their indirect activation due to effects leading to membrane depolarization. Although Galizzi et al 12 reported vasopressin-induced decrease of calcium current in whole-cell voltage-clamp experiments, comparison of our results is uncertain since a full kinetic or voltage-dependence description of the currents was not presented and experimental conditions differed. We have used the whole-cell voltage-clamp technique to study the calcium currents in A7r5 cells. Using this approach in which membrane potential is controlled, we have shown that the L-type calcium conductance is increased within minutes after exposure to phorbol esters.
In the A7r5 rat aortic cell line, we have identified two distinct voltage-dependent calcium currents, which are similar to the T-type (low-threshold, rapidly inactivating) and L-type (high-threshold, slowly inactivating) calcium currents described in other vascular preparations, including rat mesenteric artery," rat vein, 21 and the related A10 cell line. 20 The L-type current in the A7r5 cells also exhibits the expected dihydropyridine sensitivity and selectively higher barium conductance previously observed. Under conditions designed to isolate the slow, L-type current, our data demonstrate that the active phorbol esters, TPA and PDBu, cause an acute increase in the peak whole-cell current when applied in the external bath. This effect did not require pretreatment of the cells with phorbol ester as in a previous study 14 and was abolished by the dihydropyridine antagonist, nitrendipine. Further, the increases were measured relative to the pre-phorbol control levels shortly after establishing whole-cell patch-clamp, and therefore were increases beyond the possible reversal or reduction of the effects of rundown. While Armstrong and coworkers 25 have shown that A-kinase will reverse rundown of L-type current in GH 3 cells, such properties are not established for protein kinase C. These data suggest that, in this vascular smooth muscle cell line, activation of protein kinase C by phorbol ester directly or indirectly causes a secondary increase of the slow, L-type voltage-activated calcium conductance. Such an increase could occur through either an increase in the number of channels available for voltageactivation (i.e., "recruitment""-26 ) or an increase in single-channel open probability or conductance, or both. Activators of protein kinase C have been shown to increase calcium currents in molluscan neurons 1413 and to decrease calcium currents in chick dorsal root ganglion cells. 16 Protein kinase C is known to cause phosphorylation of several intracellular and membrane components. 1 -2 While activation of protein kinase C may, therefore, cause the phosphorylation of the Ltype calcium channel or a regulatory protein in this case, resulting in increased voltage-activated current through an increased number of available channels, such a conclusion is beyond the scope of our results.
The voltage-dependent inactivation of the T-type current allowed us to study the isolated L-type current as a likely factor in the dihydropyridine-sensitive modulation by phorbol esters found in calcium flux studies. However, the overlapping activation ranges of the two currents and intervening rundown complicated accurate current subtraction and prevented reliable measurements of the fully-activated barium T-type current over time. As Bean 18 -19 and others have shown, T-type currents are not completely insensitive to dihydropyridines, and with their lower activation threshold and higher calcium (rather than barium) conductance as compared to L-type channels, T-type channels may play a significant part in calcium flux studies. We are at present unable to accurately describe modulation of T-type current by dihydropyridines or phorbol esters, but as technical limitations allow, this important information will aid the understanding of both flux and electrophysiological results. If T-type currents were decreased by phorbol ester, then flux studies in which both types of calcium current are activated (as by potassium chloride depolarization), but modulated in opposing directions, may well yield variable and apparently contradictory results. Therefore, electrophysiological studies are needed to unambiguously describe the responses of calcium channels to regulatory agents.
Our observations indicate that protein kinase C can modulate calcium current through voltage-dependent calcium channels. If these findings in A7r5 cells reflect events in vascular smooth muscle in situ, they raise the possibility that a protein kinase C-mediated calcium current is involved in the regulation of calcium homeostasis during vascular contraction. These findings further provide a mechanism by which hormones that activate protein kinase C through phosphoinositide hydrolysis may influence calcium influx.
